PENATALAKSANAAN STROKE TROMBOTIK: PELUANG PENINGKATAN PROGNOSIS PASIEN
DOI:
https://doi.org/10.22219/sm.v7i1.1088Abstract
Stroke is a disease that needs multidisciplinary approach and the incident is still increasing. Primary precaution, secondary precaution and tertiary precaution are needed to reduce the incident of stroke and number of impairment. Many progress of the studies about treatments for ischemic thrombotic stroke are hold great promise for the better outcome. Thrombolytic therapy is has a main role in the acute phase treatment for the vascular target but the window therapy is narrow. There is important to overcome strategies to enhance the efficacy of thrombolytic therapy. Besides, neuroprotective agents are also important to decrease the number of disability because they are used to protect the ischemic neuron from the irreversible injury. In animal models of stroke neuroprotective agents are also hold great promise but investigators are still searching for a safe and effective agent that can limit ischemic damage in human stroke. Clinical trials are still needed to improve a better guideline of ischemic thrombotic stroke.
Keyword: stroke, thrombotic, guideline.
Downloads
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.